Cleared Traditional

K093993 - LIPISCAN IVUS IMAGING SYSTEM MODEL NIRS-MC7-70 (FDA 510(k) Clearance)

Class II Cardiovascular device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K093993 · Infraredx, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2010
Decision
188d
Days
Class 2
Risk

K093993 is an FDA 510(k) clearance for the LIPISCAN IVUS IMAGING SYSTEM MODEL NIRS-MC7-70. Classified as Catheter, Intravascular, Plaque Morphology Evaluation (product code OGZ), Class II - Special Controls.

Submitted by Infraredx, Inc. (Burlington, US). The FDA issued a Cleared decision on June 30, 2010 after a review of 188 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1200 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Infraredx, Inc. devices

Submission Details

510(k) Number K093993 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 24, 2009
Decision Date June 30, 2010
Days to Decision 188 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
63d slower than avg
Panel avg: 125d · This submission: 188d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code OGZ Catheter, Intravascular, Plaque Morphology Evaluation
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1200
Definition Catheter Used For Delivery Of A Sensing Modality To A Coronary Or Peripheral Artery Region For Determination Of Atherosclerotic Plaque Characteristics. For Examination Of Morphologic Features Of Coronary Or Peripheral Artery Lesions Or Plaques.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.